A 44-year-old woman came in with labs that would make most cardiologists pause: triglycerides above 400 and an A1C above 10. She had tried five different diets over the past three years. She was eating less than she had at any point in her adult life. The weight was not moving. Her primary care physician had told her she needed more discipline. What she actually needed was for someone to look at what was happening inside her metabolism, because the problem was not discipline. It was insulin resistance, thyroid dysfunction, and hormonal collapse, none of which respond to willpower.
Within two months of properly targeted treatment, she had lost around 15 pounds. More importantly, her labs were moving in a direction that her previous approach had never produced. The difference was not a new diet. It was understanding why the diet was failing.
Insulin Resistance Is the Lock
The most fundamental obstacle to fat loss for a significant portion of the adult population is insulin resistance. Understanding how it works explains why eating less often does not produce the expected results.
When you eat carbohydrates, blood glucose rises. Insulin is released by the pancreas to move that glucose into cells, where it is used for energy or stored. This system works properly when cells are responsive to insulin’s signal. Insulin resistance occurs when cells become less responsive, requiring the pancreas to produce more and more insulin to do the same job. Blood glucose stays elevated longer. Insulin stays elevated longer.
Here is the critical piece: insulin is a fat-storage hormone. When insulin is elevated, the body is in fat-storage mode. Fat release (lipolysis) is actively blocked. A person with chronically elevated insulin from insulin resistance cannot effectively access stored fat for energy, regardless of how much they cut their caloric intake. The body has essentially locked the fat stores.
When someone with insulin resistance eats less, the body responds by reducing metabolic rate to match the lower intake. The fat stores remain locked. The result is a person who is eating very little, feeling hungry, losing muscle (not fat), and not losing weight. This is not a character flaw. It is a metabolic state that cannot be overcome with more restriction.
Resolving insulin resistance requires a specific approach: reducing dietary inputs that spike insulin (primarily refined carbohydrates and sugar), supporting the metabolic pathways that improve insulin sensitivity, and often adding targeted interventions like exercise programming focused on large muscle groups, certain supplements, or medications depending on the severity.
What Thyroid Has to Do With It
The thyroid gland regulates metabolic rate by controlling how efficiently cells produce energy from nutrients. The active thyroid hormone, T3, drives ATP production in mitochondria. When T3 is adequate, the body runs at full metabolic capacity. When T3 is low or its conversion from the inactive form T4 is impaired, metabolism slows across every cell in the body.
The body interprets low T3 the same way it interprets starvation. Specific neurons in the hypothalamus, including neuropeptide Y and POMC neurons, sense the low metabolic signal and respond by increasing hunger, reducing energy expenditure, and directing the body to preserve fat stores. This is the same neurological response triggered by caloric restriction. A person with subclinical hypothyroidism who cuts calories is activating two starvation signals simultaneously and wondering why nothing works.
Standard thyroid testing typically measures TSH only, which is a pituitary signal rather than a direct measure of thyroid hormone activity. A person can have normal TSH and significantly low free T3, particularly if the conversion enzyme pathway is impaired. Testing free T3 and reverse T3 alongside TSH gives a complete picture of what the thyroid is actually delivering to the body’s cells.
Sleep Is a Metabolic Variable
Sleep deprivation is one of the most effective ways to guarantee that weight loss interventions fail. This is not a soft lifestyle observation. The hormonal effects of insufficient sleep are direct and measurable.
Sleep deprivation raises ghrelin, the hunger-stimulating hormone, and lowers leptin, the satiety hormone. In practical terms, this means that a sleep-deprived person is hungrier, gets full less easily, and experiences stronger cravings, particularly for carbohydrates, which provide a quick energy source when the body is running on inadequate recovery. Population-level sleep duration has declined approximately one hour over the past 50 years. The obesity curve over that same period is not coincidental.
Sleep deprivation also elevates cortisol and impairs insulin sensitivity, compounding the metabolic obstacles already present. A person trying to address insulin resistance while sleeping five to six hours a night is working against their own intervention.
Testosterone and Body Composition
Testosterone plays an often-unappreciated role in body composition and metabolic function for both men and women. It directly improves insulin sensitivity, meaning that adequate testosterone makes the insulin system work more efficiently and reduces the metabolic obstacles to fat loss. It improves nutrient partitioning, meaning that the food consumed is more likely to be directed toward muscle maintenance and energy use rather than fat storage.
In men, low testosterone also affects the dopaminergic system. Testosterone supports dopamine production. When testosterone drops, dopamine drops with it. Low dopamine raises prolactin, which further suppresses testosterone in a reinforcing loop. The behavioral consequence is reduced motivation, including reduced motivation to exercise, follow through on dietary changes, or engage with the effort that weight loss requires. Framing this as a motivational failure misses that the motivation problem is chemically driven and will not respond to better willpower.
In women, testosterone at appropriate physiological levels (not the high levels used in performance contexts) supports similar metabolic and motivational benefits. Women with low-normal testosterone frequently describe a reduction in drive and physical capacity that improved significantly when testosterone was addressed.
GLP-1 Medications: Useful but Not for Everyone
GLP-1 receptor agonists, primarily semaglutide and tirzepatide, have become widely discussed tools for weight loss. They work by slowing gastric emptying, reducing appetite, and improving insulin sensitivity. For many patients, they produce meaningful results.
But the clinical reality is more nuanced. Approximately 40 percent of patients do not tolerate semaglutide due to GI side effects including nausea, vomiting, and diarrhea. Tirzepatide, which acts on both GLP-1 and GIP receptors, tends to have better tolerability and more consistent results in clinical practice, making it the preferred option when GLP-1 medications are appropriate.
More importantly, these medications are not intended for long-term use beyond approximately one year. They are a tool to break through the metabolic resistance phase while the underlying drivers are being addressed, not a permanent solution. A patient who uses GLP-1 medications without fixing insulin resistance, optimizing thyroid function, addressing sleep, and supporting hormonal balance will likely regain the weight when the medication stops, because the conditions that caused the problem were never resolved.
GLP-1 medications work best as part of a comprehensive metabolic program, not as a standalone intervention.
The Elimination Diet as Diagnostic Tool
In patients with complex metabolic presentations, a strict elimination diet serves as both a diagnostic and therapeutic tool. By removing the most common inflammatory foods, processed carbohydrates, seed oils, alcohol, and dairy, and then systematically reintroducing them, it is possible to identify which specific inputs are driving inflammation and metabolic dysfunction in that individual patient.
The carnivore diet, while not appropriate as a long-term protocol for most people, serves a specific clinical purpose in this context: it eliminates virtually every inflammatory variable simultaneously, providing a clean baseline from which to evaluate what the body does without those inputs. Patients who show dramatic metabolic improvement on a temporary carnivore protocol often have food-driven inflammation that was invisible until it was removed.
This information is clinically actionable. It tells the provider which dietary variables are the highest leverage for that specific patient rather than applying a generic protocol.
What Changes First
The frustrating reality for patients who want to lose weight is that the intervention that produces the most visible external result, eating less, is often the least effective tool when the underlying metabolic state is broken. The more effective sequence, though it produces less immediate visible change, is:
Identify and address insulin resistance through targeted dietary shifts and appropriate medical support. Test and optimize thyroid function. Assess and address hormonal deficiencies, particularly testosterone. Improve sleep duration and quality. Add exercise programming focused on compound movements using large muscle groups (squats, deadlifts, rows) rather than cardio, which has minimal impact on metabolic rate. Then, if appropriate, add GLP-1 support for the acute phase while the underlying systems stabilize.
The woman with triglycerides above 400 and an A1C above 10 did not need more discipline. She needed a provider who understood that her metabolism was in a state that made conventional dietary advice not just unhelpful but actively counterproductive. The approach changed, the results followed.
About the Author: This article was written by the clinical education team at Med Matrix, a functional medicine clinic in South Portland, Maine. Med Matrix serves over 3,000 patients with a provider team that specializes in root-cause testing, hormone optimization, and personalized treatment plans.